Donald Trump's tariffs will impact Indian medicine exports. This policy targets branded and patented drugs. Indian generic drug makers face challenges. They must explore markets beyond the United States. China offers a destination for Indian pharma companies. This shift will alter global drug industry dynamics. India needs to adapt its export strategy.
US tariff a bitter pill for Indian pharma
